ArticlebioRxiv : the preprint server for biology2025
HER2; p53 Co-mutated Cancers Show Increased Histone Acetylation and are Sensitive to Neratinib plus Trastuzumab Deruxtecan.
Xiaoqing Cheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.